Propofol can suppress cervical cancer cell viability, and enhance cisplatin-mediated apoptosis by inhibiting the EGFR/JAK2/STAT3 pathway, thereby enhancing the anti-tumor effect of cisplatin (Li et al., 2017). This evidence concerns the gene JAK2 and neoplasm.